Vivani Medical, Inc.
VANI Nasdaq
SEC CIK 1266806
Follow Vivani Medical
Weekly email: filings, results
Net income
−$7.3M
−11% vs same quarter last year
EPS, diluted
−$0.08
+27.3% vs same quarter last year
Operating cash flow
−$6.4M
−0.6% vs same quarter last year
Operating income
−$7.5M
−12% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $0 | - |
| FY24 | $0 | - |
| FY23 | - | - |
| FY22 | - | −$13.9M |
| FY21 | - | −$12.8M |
| FY20 | - | −$14.9M |
| FY19 | $3.4M | −$33.6M |
| FY18 | $6.9M | −$35.1M |
| FY17 | $8M | −$28.5M |
| FY16 | $4M | −$33.2M |
| FY15 | $8.9M | −$20M |
| FY14 | $3.4M | −$35.2M |
| FY13 | $1.6M | −$23M |
| FY12 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | - | - |
| FY24 | - | - | - |
| FY23 | - | - | - |
| FY22 | - | - | - |
| FY21 | - | - | - |
| FY20 | - | - | - |
| FY19 | 36.3% | −1004.9% | −994.1% |
| FY18 | 29.1% | −509.9% | −508.6% |
| FY17 | 35.7% | −359.2% | −358.1% |
| FY16 | −152.3% | −830.2% | −829.5% |
| FY15 | 41.1% | −225.2% | −224.9% |
| FY14 | −4.7% | −624.5% | −1035.3% |
| FY13 | −259.7% | −1150% | −1467.7% |
| FY12 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$25.5M |
| FY24 | −$21.3M |
| FY23 | −$24.6M |
| FY22 | −$19.1M |
| FY21 | −$11.5M |
| FY20 | −$17.2M |
| FY19 | −$28.1M |
| FY18 | −$30M |
| FY17 | −$24.2M |
| FY16 | −$25.6M |
| FY15 | −$21.3M |
| FY14 | −$17.7M |
| FY13 | −$17.7M |
| FY12 | - |
- Vivani Medical
- Healthcare median
Show the numbers
| Year | Vivani Medical | Healthcare median |
|---|---|---|
| FY25 | - | −30.6% |
| FY24 | - | −47% |
| FY23 | - | −58% |
| FY22 | - | −80.4% |
| FY21 | - | −71.8% |
| FY20 | - | −62.2% |
| FY19 | −994.1% | −46.2% |
| FY18 | −508.6% | −49.6% |
| FY17 | −358.1% | −45.9% |
| FY16 | −829.5% | −36% |
| FY15 | −224.9% | −37.8% |
| FY14 | −1035.3% | −35.5% |
| FY13 | −1467.7% | −37.1% |
| FY12 | - | −29.1% |